Drugs / inhaled hypertonic saline
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01887197 | Jun 2013 → Dec 2017 | cystic fibrosis | Tim Corcoran | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | inhaled hypertonic saline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01887197 ↗ |
| Route | Inhaled | “nebulized hypertonic saline (7%)” NCT01887197 ↗ |